Loading company
Phibro Animal Health Corp.
PAHC · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
Next earnings: November 4, 2026
$35.52-0.6%Sep 29 close
- 1M
- -5.4%
- 6M
- -32.9%
- 1Y
- -11.1%
- 5Y
- +88.7%
PAHC · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
Next earnings: November 4, 2026
$35.52-0.6%Sep 29 close
Phibro Animal Health Corp. is scheduled to report next on November 4, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $396.7M | $378.7M | +4.77% |
| Profit | $21.7M | $17.2M | +26.05% |
| Profit per share | $0.53 | $0.43 | +23.26% |
| Free Cash Flow | $5.2M | $8.1M | -35.73% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Phibro Animal Health Corp.’s Item 2.02 8-K filed August 26, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Phibro Animal Health Corp. has no earnings call transcript available.